Synexa Insights
The Latest Insights From Our Scientists
From Pottiphar to Potts: Skeletal TB from Ancient Egypt to the Present Day
Exploring the origins of TB in Ancient Egypt to present day biomarkers used to identify and treat the disease.…
Bridging the Gap: Translating Animal Model Findings to Clinical Oncology Breakthroughs
This blog delves into the historical significance, current challenges, and promising innovations shaping translational science research.…
Cardiovascular complications in chronic kidney disease: New biomarkers and treatment
Individuals with chronic kidney disease (CKD) are at a disproportionately high risk of cardiovascular events. Mechanistically, high salt and water…
Modelling Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP): A rare autoimmune disease
On this rare disease day, we delve into Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP).…
World Cancer Day 2024: Closing the gap
February 4th 2024 marks World Cancer Day and the primary theme for this year is ‘closing the gap' in cancer…
Mycobacterium leprae: The lazy cousin to Tuberculosis
Leprosy, today known as Hansen's disease, is still prevalent in 2024. In this blog, we investigate look at the challenges,…
The criticality of early detection of pre-eclampsia: New biomarkers
Pre-eclampsia (PE) is a condition that affects up to 8% of pregnancies worldwide.…
Top 3 Biotech Trends in 2024 | Dr. Caroline Beltran
Dr. Caroline Beltran shares her top 3 trends to watch out for in 2024.…
Top 3 Biotech Trends in 2024 | Dr. Nicholas Woudberg
Read on as Dr. Nicholas Woudberg shares 3 key biotech trends to expect in 2024.…
Bioanalytical Strategies for Cell Therapy Clinical Trials
As we delve into the intricacies of cell therapies and their unique mechanisms of action, the need arises for tailored…
Uncovering tissue complexity through spatial biology
Discover how spatial biology is transforming oncology research.…
The standardization of synuclein seed amplification assays
In this blog, we explore Seed Amplification Assays (SAA) in detecting α-synuclein aggregates - a potential prognostic biomarker for Parkinson's…
Improving the quality of human health
Contact us
Discuss biomarker and bioanalytical solutions to accelerate your therapeutic pipeline
